Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.
https://stemcell.co.nz/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 NZ Stem Cell Treatment Centre NZ Stem Cell Treatment Centre https://stemcell.co.nz/wp-content/themes/osmosis/images/empty/thumbnail.jpgProc Natl Acad Sci U S A. 2008 Sep 23;105(38):14692-7 Authors: Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, Pakozdi A, Koch AE Regulation of IL-6 transsignaling by the administration of soluble gp130 (sgp130) receptor to capture the IL-6/soluble IL-6R complex has shown promise for the treatment of rheumatoid arthritis (RA).…
read more